shaping the future of clinical trials

A modern, full-service CRO redefining clinical research across Central and Eastern Europe and Kazakhstan. With an innovative approach and deep regional insight, we simplify clinical trials — delivering smart solutions tailored to each study. Let’s move research forward, together.

LET'S MAKE YOUR TRIAL WORK

At Viacrystal, we turn ideas into impactful clinical research. Backed by a trusted network of investigators and medical experts, our team has recently completed several successful trials. Explore how our experience and regional reach can support your next study.

Latest projects

LEARN MORE

We support your trial every step of the way, offering end-to-end services. With our experienced team and regional network, we simplify the trial process so you can focus on the science.

full-cycle services

LEARN MORE

COUNTRIES OF PRESENCE

Hungary

Serbia

Croatia

Slovenia

Bosnia and Herzegovina
Türkiye
Kazakhstan
Slovakia
Czech Republic
Latvia
Lithuania
Estonia

viacrystal connects you with experts

Dr. SAŠA SRETENOVIĆ

Vascular surgeon

SERBIA

"As a Principal Investigator, my priority is ensuring the highest standards of clinical research while keeping patient safety at the core. Every trial is an opportunity to advance medical science and bring innovative treatments to those who need them most"

LEARN MORE AND BOOK MEETING

Build Study Business Plan That Attracts Sponsors

PREPARING TO SECURE FUNDING

FOR YOUR TRIAL?

Our CEO and Strategic Consultant offer expert-level guidance to help you develop a compelling study business plan.

For a fixed fee, you’ll receive support on:

Budgeting
Project structure
Strategic positioning
Preliminary feasibility
Optimal study geography
Insights into local standard of care

ASK VIACRYSTAL NOW

THERAPEUTIC AREAS AND PROJECTS

Clinical trials in psychiatry require careful attention to patient recruitment and retention, as participation often involves long-term follow-up and sensitive assessments. Ensuring ethical considerations, clear communication, and patient comfort are essential for reliable outcomes and compliance.

NOSOLOGY: Schizophrenia

YEAR / PERIOD: 2018 - 2020 and 2022 - 2025
PHASE: III
MAIN GOAL: To complete enrollment in 6 months

RESULT: All selected site have enrolled estimated number of patients and study was completed in time

Neurological trials demand highly specific inclusion criteria, long observation periods, and collaboration with Key Opinion Leaders for accurate diagnosis and patient eligibility. Early feasibility assessments and strong investigator networks are crucial for enrollment and data integrity.

NOSOLOGY: Alzheimer's disease

YEAR / PERIOD: 2023 - 2025
PHASE: II
MAIN GOAL: To rescue study

RESULT: Croatian sites have enrolled the missing number of patients

NOSOLOGY: Stroke

YEAR / PERIOD: 2022 - 2023
PHASE: III
MAIN GOAL: Very short enrollment timelines

RESULT: In spite of the high complexity of the project, we have managed to activate 9 Hungarian sites and each enrolled patient.

Trials in women’s health must account for hormonal cycles, reproductive status, and age-specific considerations. Recruitment strategies should be inclusive and sensitive, and protocols need to address safety concerns specific to female participants.

NOSOLOGY: Endometriosis

YEAR / PERIOD: 2018 - 2021
PHASE: III
MAIN GOAL: To finish enrollment in 6-8 months

RESULT: Due to Covid enrollment was slowed down but completed in few months later than planned

Timing is everything in trials related to seasonal conditions such as allergies or respiratory illnesses. Protocols must be tightly scheduled around peak seasons, with efficient site activation and logistics in place to ensure timely recruitment and data collection.

NOSOLOGY: Rhinosinusitis

YEAR / PERIOD: 2022 - 2023
PHASE: III
MAIN GOAL: Very short enrollment timelines

RESULT: Croatian sites had became the best enroller sites

These trials often face challenges due to complex disease presentations, fluctuating symptoms, and comorbidities. Biomarker selection, patient stratification, and long-term safety monitoring are critical for producing meaningful and applicable results.

NOSOLOGY: Transthyretin Amyloid Polyneuropathy (ATTR-PN)

YEAR / PERIOD: 2021 - 2022
PHASE: II
MAIN GOAL: To activate 2 sites in 3 months

RESULT: Hungarian sites have been activated in time

focus on innovation while we handle details

WHAT WE OFFER

STUDY PLANNING

Laying foundation for success

START-UP ACTIVITIES

Setting trial in motion

REGULATORY
& ETHICS

Navigating approvals with confidence

OPERATIONAL SUPPORT

Keeping your trial on track

DATABASE OPERATIONS

Secure and structered data handling

LOGISTICS

Everything at right place and time

MEET VIACRYSTAL TEAM

Assel Sarsikeyeva

CEO, MSc, MBA

Assel brings years of experience and expertise to our team. She holds a Master of environmental sciences and has worked in the industry for over a decade. Assel is passionate about clinical research and is dedicated to ensuring that our clients receive the highest quality services possible.

LET'S unlock success of trial together

shaping the future of clinical trials

Latest projects

full-cycle services

COUNTRIES OF PRESENCE

viacrystal connects you with experts

Build Study Business Plan That Attracts Sponsors

THERAPEUTIC AREAS AND PROJECTS

focus on innovation while we handle details

WHAT WE OFFER

STUDY PLANNING

START-UP ACTIVITIES

REGULATORY & ETHICS

OPERATIONAL SUPPORT

DATABASE OPERATIONS

LOGISTICS

MEET VIACRYSTAL TEAM

LET'S unlock success of trial together

REGULATORY
& ETHICS